Skip to main content

Want a detailed portfolio tracker?

Progyny (PGNY) Revenue (2018 - 2026)

Progyny (PGNY) revenue from Sep 30, 2018 to Mar 31, 2026. The TTM Progyny (PGNY) revenue is $1.29B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Progyny (PGNY) Revenue CAGR table

PeriodCAGR
1 Year TTM+6.59%
3 Years TTM+13.99%
5 Years TTM+27.36%
All Time TTM+37.32%

Annual Revenue change of Progyny (PGNY)

YearRevenueChange
2026$329M-74.51%
2025$1.29B+10.40%
2024$1.17B+7.22%
2023$1.09B+38.34%
2022$787M+57.19%
2021$501M+45.17%
2020$345M+50.15%
2019$230M+117.91%
2018$105M+116.96%
2017$49MN/A

Comparison Progyny (PGNY) five years revenue CAGR with competitors

Progyny (PGNY) five years revenue CAGR is 27.36%.

TickerNamefive years Revenue CAGRUpside
ALHCAlignment Healthcare Inc33.65%+23.03%
HUMHumana Inc27.17%-0.68%
CLOVClover Health Investments Corp - Class A25.59%-6.46%
MOHMolina Healthcare Inc16.07%-41.25%
UNHUnitedhealth Group Inc11.33%-58.57%
ELVElevance Health Inc11.28%-58.77%
CICigna Group (The)11.27%-58.79%
CNCCentene Corp10.41%-61.96%
CVSCVS Health Corp8.52%-68.86%